Emodin and Aloe-Emodin suppress breast cancer cell proliferation through ER α inhibition

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Huang, Pao Hsuan ^a   Huang, Chih Yang ^b,c   Chen, Mei Chih ^a,d   Lee, Yueh Tsung ^a,e   Yue, Chia Herng ^a,f   Wang, Hsin Yi ^a,g   Lin, Ho ^a,c,d  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b ASIA UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e CHANG BING SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

^f TUNGS' TAICHUNG METROHARBOR HOSPITAL   (Taiwan)

^g TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALOE EMODIN; EMODIN; ESTROGEN RECEPTOR ALPHA; HEAT SHOCK PROTEIN 90;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CELL PROLIFERATION; DOWN REGULATION; DRUG MECHANISM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN STABILITY; UBIQUITINATION;

EID: 84880178686     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/376123     Document Type: Article

References (39)

1. Huang Q., Lu G., Shen H.-M., Chung M. C. M., Choon N. O., Anti-cancer properties of anthraquinones from rhubarb. Medicinal Research Reviews 2007 27 5 609 630 2-s2.0-34548047015 10.1002/med.20094 (Pubitemid 47282446)
2. Dutta A., Bandyopadhyay S., Mandal C., Chatterjee M., Aloe vera leaf exudate induces a caspase-independent cell death in Leishmania donovani promastigotes. Journal of Medical Microbiology 2007 56 5 629 636 2-s2.0-34248158942 10.1099/jmm.0.47039-0 (Pubitemid 46717486)
3. Wang H.-H., Chung J.-G., Emodin-induced inhibition of growth and DNA damage in the Helicobacter pylori. Current Microbiology 1997 35 5 262 266 2-s2.0-0030697125 10.1007/s002849900250 (Pubitemid 27494919)
4. Chang C.-H., Lin C.-C., Yang J.-J., Namba T., Hattori M., Anti-inflammatory effects of emodin from Ventilago leiocarpa. American Journal of Chinese Medicine 1996 24 2 139 142 2-s2.0-0030347352 (Pubitemid 126765683)
5. Cha T.-L., Qiu L., Chen C.-T., Wen Y., Hung M.-C., Emodin down-regulates androgen receptor and inhibits prostate cancer cell growth. Cancer Research 2005 65 6 2287 2295 2-s2.0-16844386205 10.1158/0008-5472.CAN-04-3250 (Pubitemid 40490138)
6. Matsuda H., Shimoda H., Morikawa T., Yoshikawa M., Phytoestrogens from the roots of Polygonum cuspidatum (Polygonaceae): structure-requirement of hydroxyanthraquinones for estrogenic activity. Bioorganic and Medicinal Chemistry Letters 2001 11 14 1839 1842 2-s2.0-0035939373 10.1016/S0960-894X(01) 00318-3 (Pubitemid 32675300)
7. Kang S. C., Lee C. M., Choung E. S., Bak J. P., Bae J. J., Yoo H. S., Kwak J. H., Zee O. P., Anti-proliferative effects of estrogen receptor-modulating compounds isolated from Rheum palmatum. Archives of Pharmacal Research 2008 31 6 722 726 2-s2.0-45749113031 10.1007/s12272-001-1218- 1
8. Acconcia F., Kumar R., Signaling regulation of genomic and nongenomic functions of estrogen receptors. Cancer Letters 2006 238 1 1 14 2-s2.0-33744943264 10.1016/j.canlet.2005.06.018 (Pubitemid 43851144)
9. Ali S., Coombes R. C., Endocrine-responsive breast cancer and strategies for combating resistance. Nature Reviews Cancer 2002 2 2 101 112 2-s2.0-0036488531 (Pubitemid 37328797)
10. Osborne C. K., Tamoxifen in the treatment of breast cancer. The New England Journal of Medicine 1998 339 22 1609 1618 2-s2.0-0032569831 10.1056/NEJM199811263392207 (Pubitemid 28536137)
11. Colditz G. A., Hankinson S. E., Hunter D. J., Willett W. C., Manson J. E., Stampfer M. J., Hennekens C., Rosner B., Speizer F. E., The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. The New England Journal of Medicine 1995 332 24 1589 1593 2-s2.0-0029056755 10.1056/NEJM199506153322401
12. Adlercreutz H., Mazur W., Phyto-oestrogens and Western diseases. Annals of Medicine 1997 29 2 95 120 2-s2.0-0030976331 (Pubitemid 27226319)
13. Chen M. C., Huang C. Y., Hsu S. L., Lin E., Ku C. T., Lin H., Chen C. M., Retinoic acid Induces apoptosis of prostate cancer DU145 cells through Cdk5 overactivation. Evidence-Based Complementary and Alternative Medicine 2012 2012 11 580736 10.1155/2012/580736
14. Lin H., Wang P. S., Inhibitory effects of digoxin on testosterone production in rat Leydig cells. Adaptive Medicine 2012 4 165 172
15. Lin H., Lin T.-Y., Juang J.-L., Abl deregulates Cdk5 kinase activity and subcellular localization in Drosophila neurodegeneration. Cell Death and Differentiation 2007 14 3 607 615 2-s2.0-33847025578 10.1038/sj.cdd.4402033
16. Lin H., Chen M.-C., Chiu C.-Y., Song Y.-M., Lin S.-Y., Cdk5 regulates STAT3 activation and cell proliferation in medullary thyroid carcinoma cells. Journal of Biological Chemistry 2007 282 5 2776 2784 2-s2.0-34047251311 10.1074/jbc.M607234200 (Pubitemid 47084342)
17. Lin H., Chen M.-C., Ku C.-T., Cyclin-dependent kinase 5 regulates steroidogenic acute regulatory protein and androgen production in mouse Leydig cells. Endocrinology 2009 150 1 396 403 2-s2.0-58149469225 10.1210/en.2008-0496
18. Lin H., Juang J.-L., Wang P. S., Involvement of Cdk5/p25 in digoxin-triggered prostate-cancer cell apoptosis. Journal of Biological Chemistry 2004 279 28 29302 29307 2-s2.0-3142689920 10.1074/jbc.M403664200 (Pubitemid 38915807)
19. Hsu F.-N., Chen M.-C., Chiang M.-C., Lin E., Lee Y.-T., Huang P.-H., Lee G.-S., Lin H., Regulation of androgen receptor and prostate cancer growth by cyclin-dependent kinase 5. Journal of Biological Chemistry 2011 286 38 33141 33149 2-s2.0-80053047154 10.1074/jbc.M111.252080
20. Chen M.-C., Wang S.-W., Kan S.-F., Tsai S.-C., Wu Y.-C., Wang P. S., Stimulatory effects of propylthiouracil on pregnenolone production through upregulation of steroidogenic acute regulatory protein expression in rat granulosa cells. Toxicological Sciences 2010 118 2 667 674 2-s2.0-78549236170 10.1093/toxsci/kfq302 kfq302
21. Dalvai M., Bystricky K., Cell cycle and anti-estrogen effects synergize to regulate cell proliferation and er target gene expression. PLoS One 2010 5 6 2-s2.0-77956208216 10.1371/journal.pone.0011011 e11011
22. Heldring N., Pike A., Andersson S., Matthews J., Cheng G., Hartman J., Tujague M., Ström A., Treuter E., Warner M., Gustafsson J.-Å., Estrogen receptors: how do they signal and what are their targets. Physiological Reviews 2007 87 3 905 931 2-s2.0-34447523339 10.1152/physrev.00026.2006 (Pubitemid 47084672)
23. Miyoshi Y., Murase K., Saito M., Imamura M., Oh K., Mechanisms of estrogen receptor- α upregulation in breast cancers. Medical Molecular Morphology 2010 43 4 193 196 2-s2.0-79952664143 10.1007/s00795-010-0514-3
24. Fan M., Park A., Nephew K. P., CHIP (carboxyl terminus of Hsc70-interacting protein) promotes basal and geldanamycin-induced degradation of estrogen receptor- α Molecular Endocrinology 2005 19 12 2901 2914 2-s2.0-28144439277 10.1210/me.2005-0111 (Pubitemid 41697710)
25. Walker R. A., Oestrogen receptor and its potential role in breast cancer development. The Journal of Pathology 1999 188 3 229 230 (Pubitemid 29317762)
26. Mangelsdorf D. J., Thummel C., Beato M., Herrlich P., Schütz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., Evans R. M., The nuclear receptor super-family: the second decade. Cell 1995 83 6 835 839 2-s2.0-0012473279
27. Hall J. M., Couse J. F., Korach K. S., The multifaceted mechanisms of estradiol and estrogen receptor signaling. Journal of Biological Chemistry 2001 276 40 36869 36872 2-s2.0-0035813112 10.1074/jbc.R100029200
28. Jordan V. C., Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer. British Journal of Pharmacology 2006 147 1 S269 S276 2-s2.0-30444434216 10.1038/sj.bjp.0706399 (Pubitemid 43077285)
29. Murkies A. L., Wilcox G., Davis S. R., Phytoestrogens. Journal of Clinical Endocrinology and Metabolism 1998 83 2 297 303 2-s2.0-0031992548 10.1210/jc.83.2.297 (Pubitemid 28496496)
30. Nikander E., Kilkkinen A., Metsä-Heikkilä M., Adlercreutz H., Pietinen P., Tiitinen A., Ylikorkala O., A randomized placebo-controlled crossover trial with phytoestrogens in treatment of menopause in breast cancer patients. Obstetrics and Gynecology 2003 101 6 1213 1220 2-s2.0-0038547759 10.1016/S0029-7844(03)00232-1 (Pubitemid 36694346)
31. Imai Y., Tsukahara S., Asada S., Sugimoto Y., Phytoestrogens/flavonoids reverse breast cancer resistance protein/ABCG2-mediated multidrug resistance. Cancer Research 2004 64 12 4346 4352 2-s2.0-3042569646 10.1158/0008-5472.CAN-04- 0078 (Pubitemid 38802442)
32. Jayasuriya H., Koonchanok N. M., Geahlen R. L., McLaughlin J. L., Chang C.-J., Emodin, a protein tyrosine kinase inhibitor from Polygonum cuspidatum. Journal of Natural Products 1992 55 5 696 698 2-s2.0-0026625611 10.1021/np50083a026
33. Zhang L., Chang C.-J., Bacus S. S., Hung M.-C., Suppressed transformation and induced differentiation of HER-2/neu-overexpressing breast cancer cells by emodin. Cancer Research 1995 55 17 3890 3896 2-s2.0-0029118536
34. Zhang L., Hung M.-C., Sensitization of HER-2/neu-overexpressing non-small cell lung cancer cells to chemotherapeutic drugs by tyrosine kinase inhibitor emodin. Oncogene 1996 12 3 571 576 2-s2.0-0030067015 (Pubitemid 26059652)
35. Chou T.-H., Liang C.-H., The molecular effects of Aloe-Emodin (AE)/liposome-AE on human nonmelanoma skin cancer cells and skin permeation. Chemical Research in Toxicology 2009 22 12 2017 2028 2-s2.0-73849108782 10.1021/tx900318a
36. Yan Y.-Y., Zheng L.-S., Zhang X., Chen L.-K., Singh S., Wang F., Zhang J.-Y., Liang Y.-J., Dai C.-L., Gu L.-Q., Zeng M.-S., T. Talele T., Chen Z.-S., Fu L.-W., Blockade of Her2/neu binding to Hsp90 by emodin azide methyl anthraquinone derivative induces proteasomal degradation of Her2/neu. Molecular Pharmaceutics 2011 8 5 1687 1697 2-s2.0-80053506847 10.1021/mp2000499
37. Murakami Y., Matsufuji S., Kameji T., Hayashi S., Igarashi K., Tamura T., Tanaka K., Ichihara A., Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination. Nature 1992 360 6404 597 599 2-s2.0-0026714435 10.1038/360597a0 (Pubitemid 23000711)
38. Asher G., Shaul Y., p53 proteasomal degradation: poly-ubiquitination is not the whole story. Cell Cycle 2005 4 8 1015 1018 2-s2.0-25444445785 (Pubitemid 41365353)
39. Kocanova S., Mazaheri M., Caze-Subra S., Bystricky K., Ligands specify estrogen receptor alpha nuclear localization and degradation. BMC Cell Biology 2010 11 article 98 2-s2.0-78650846580 10.1186/1471-2121-11-98